Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alodvit
- Development stage
- Unknown
- Lead developer
- Alodia Life Sciences
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Alodvit is a multi-ingredient nutritional supplement developed and marketed by Alodia Life Sciences. It is formulated as a combination of ginseng, Lactobacillus, folic acid, and various other vitamins and minerals (including magnesium, calcium, phosphorus, and protein). Alodvit is indicated for dietary supplementation and the treatment or prevention of vitamin and mineral deficiencies resulting from illness, pregnancy, poor nutrition, or digestive disorders. It is also marketed under the brand names ALOD G and ALOD-PLUS.
- Brand names
- ALOD GALOD-PLUSAlodvit
Beyond the preview
Go deeper on Alodvit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alodvit.